The groundbreaking rise of Viagra has consistently remained a benchmark of pharmaceutical success, however its legacy within the broader market now raises questions about future yields . Alternative versions are diminishing market share, leading to anxieties that supporting companies significantly dependent to Viagra's once-dominant influence could